Vicarious Surgical Inc. (RBOT)
| Market Cap | 43.66M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -61.62M |
| Shares Out | 5.93M |
| EPS (ttm) | -10.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,232 |
| Open | 7.39 |
| Previous Close | 7.33 |
| Day's Range | 7.21 - 7.54 |
| 52-Week Range | 4.27 - 19.00 |
| Beta | 1.42 |
| Analysts | Hold |
| Price Target | 9.25 (+25.68%) |
| Earnings Date | Aug 11, 2025 |
About RBOT
Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. The company was founded in 2014 and is headquartered in Waltham, Massachusetts. [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for RBOT stock is "Hold." The 12-month stock price target is $9.25, which is an increase of 25.68% from the latest price.
News
Vicarious Surgical Announces Election of New Directors
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, ...
Toyota ($TM) | XPENG ($XPEV) | Innoviz ($INVZ) | Volkswagen ($VWAGY) Vicarious Surgical ($RBOT)
Welcome to the Green Stock News brief for Tuesday May 13th. Here are today's top headlines: Toyota (NYSE: TM) has unveiled its 2026 bZ Battery Electric Vehicle, featuring improved range, including a n...
Vicarious Surgical Inc. (RBOT) Q1 2025 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT) Q1 2025 Results Conference Call May 12, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Adam Sachs - Co-Founder and CEO Sarah Romano - CFO ...
Vicarious Surgical Reports First Quarter 2025 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Announces New Collaboration with UMass Memorial Medical Center
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced ...
Vicarious Surgical to Report First Quarter 2025 Financial Results on May 12, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Receives Continued Listing Standard Notice from the NYSE
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Announces President Transition to Board Member Role
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Inc. (RBOT) Q4 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT) Q4 2024 Earnings Conference Call March 17, 2025 4:30 PM ET Company Participants Kaitlyn Brosco - Director-IR Adam Sachs - Co-Founder and CEO Randy Clark - Presiden...
Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 17, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Announces Planned Retirement of Chief Operating Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Announces Departure of Chief Financial Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Inc. (RBOT) Q3 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco – Director-Investor Relations Adam Sachs – Co-Founder and Chief E...
Vicarious Surgical Reports Third Quarter 2024 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical to Report Third Quarter 2024 Financial Results on November 12, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript
Vicarious Surgical Inc (NYSE:RBOT) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Bill Kelly - CFO & Treasurer Adam Sachs - Co-Founder, CEO & Dire...
Vicarious Surgical Reports Second Quarter 2024 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical Announces New Hospital System Partnership with LSU Health New Orleans
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transf...
Vicarious Surgical to Report Second Quarter 2024 Financial Results on August 12, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through t...
Vicarious Surgical Announces Reverse Stock Split
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through t...
Vicarious Surgical Inc. (RBOT) Q1 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT) Q1 2024 Earnings Conference Call April 29, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - Head, Investor Relations Adam Sachs - Co-Founder and CEO Bill Kell...
Vicarious Surgical Reports First Quarter 2024 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through t...